Literature DB >> 12921008

Neuropsychological correlates of suboptimal adherence to metformin.

Marc I Rosen1, John E Beauvais, Michael O Rigsby, Jamelah T Salahi, Caitlin E Ryan, Joyce A Cramer.   

Abstract

The goal of this study was to determine if neuropsychological function is associated with adherence to prescribed medication. Altogether, 79 patients with type II diabetes at a VA primary care clinic had adherence to the antihyperglycemic drug metformin measured with MEMS caps over a 4-week period. They completed several tests of neuropsychological function: Mini-Mental Status Exam (MMSE), Trails A and B, Stroop, Digit Span, Digit Symbol, and Grooved Pegboard. In separate multivariate analyses, Stroop word score and time to complete Trails B were independently associated with adherence, as was age. Secondary analyses of the relationship between neuropsychological variables and other adherence-related measures were conducted. Low scores on the MMSE and non-Caucasian ethnicity were associated with missed appointments. None of the neuropsychological variables were associated with glycosylated hemoglobin. These results suggest that cognitive abilities should be considered when counseling patients concerning their adherence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12921008     DOI: 10.1023/a:1024257027839

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  19 in total

1.  Impact of dosage frequency on patient compliance.

Authors:  A H Paes; A Bakker; C J Soe-Agnie
Journal:  Diabetes Care       Date:  1997-10       Impact factor: 19.112

2.  Compliance and cognitive function: a methodological approach to measuring unintentional errors in medication compliance in the elderly. McGill-Calgary Drug Research Team.

Authors:  L M Isaac; R M Tamblyn
Journal:  Gerontologist       Date:  1993-12

Review 3.  Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies.

Authors:  M W Strachan; I J Deary; F M Ewing; B M Frier
Journal:  Diabetes Care       Date:  1997-03       Impact factor: 19.112

Review 4.  A critical review of interventions to increase compliance with medication-taking, obtaining medication refills, and appointment-keeping in the treatment of cardiovascular disease.

Authors:  S A Newell; J A Bowman; J D Cockburn
Journal:  Prev Med       Date:  1999-12       Impact factor: 4.018

5.  Effects of computer generated reminder charts on patients' compliance with drug regimens.

Authors:  D K Raynor; T G Booth; A Blenkinsopp
Journal:  BMJ       Date:  1993-05-01

6.  Adherence of elderly patients.to treatment with pentoxifylline.

Authors:  A Spriet; D Beiler; J Dechorgnat; P Simon
Journal:  Clin Pharmacol Ther       Date:  1980-01       Impact factor: 6.875

7.  Assessment of sulfonylurea adherence and metabolic control.

Authors:  B J Mason; J R Matsuyama; S G Jue
Journal:  Diabetes Educ       Date:  1995 Jan-Feb       Impact factor: 2.140

8.  Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease.

Authors:  L J Eldred; A W Wu; R E Chaisson; R D Moore
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-06-01

9.  Hemoglobin A1c levels in a diabetes detection program.

Authors:  J V Santiago; J E Davis; F Fisher
Journal:  J Clin Endocrinol Metab       Date:  1978-09       Impact factor: 5.958

Review 10.  Doctor-patient communication: some quantitative estimates of the role of cognitive factors in non-compliance.

Authors:  P Ley
Journal:  J Hypertens Suppl       Date:  1985-04
View more
  14 in total

1.  Predictors of Attrition in a Cohort Study of HIV Infection and Methamphetamine Dependence.

Authors:  J Cattie; M J Marquine; K A Bolden; L C Obermeit; E E Morgan; D R Franklin; A Umlauf; J M Beck; J H Atkinson; I Grant; S P Woods
Journal:  J Subst Use       Date:  2015-02-03

2.  Influence of patient and treatment factors on adherence to adjuvant endocrine therapy in breast cancer.

Authors:  Catherine M Bender; Amanda L Gentry; Adam M Brufsky; Frances E Casillo; Susan M Cohen; Meredith M Dailey; Heidi S Donovan; Jacqueline Dunbar-Jacob; Rachel C Jankowitz; Margaret Q Rosenzweig; Paula R Sherwood; Susan M Sereika
Journal:  Oncol Nurs Forum       Date:  2014-05       Impact factor: 2.172

3.  The relationship between cognitive impairment and diabetes self-management in a population-based community sample of older adults with Type 2 diabetes.

Authors:  Denise G Feil; Carolyn W Zhu; David L Sultzer
Journal:  J Behav Med       Date:  2011-04-19

Review 4.  Adherence with medications used to treat osteoporosis: behavioral insights.

Authors:  John T Schousboe
Journal:  Curr Osteoporos Rep       Date:  2013-03       Impact factor: 5.096

5.  The impact of cognitive function on medication management: three studies.

Authors:  Carol S Stilley; Catherine M Bender; Jacqueline Dunbar-Jacob; Susan Sereika; Christopher M Ryan
Journal:  Health Psychol       Date:  2010-01       Impact factor: 4.267

6.  Cognitive Behavioral Therapy for Adherence and Depression (CBT-AD) in Type 2 Diabetes.

Authors:  Jeffrey S Gonzalez; Lauren A McCarl; Deborah D Wexler D; Enrico Cagliero; Linda Delahanty; Tiffany D Soper; Valerie Goldman; Robert Knauz; Steven A Safren
Journal:  J Cogn Psychother       Date:  2010-11-01

7.  Factors associated with dropout from treatment: An exploratory study.

Authors:  Sandeep Grover; Sridhar Mallnaik; Subho Chakrabarti; Aseem Mehra
Journal:  Indian J Psychiatry       Date:  2021-02-15       Impact factor: 1.759

8.  Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based Study.

Authors:  Michel Tiv; Jean-François Viel; Frédéric Mauny; Eveline Eschwège; Alain Weill; Cécile Fournier; Anne Fagot-Campagna; Alfred Penfornis
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

Review 9.  The influence of cognition on self-management of type 2 diabetes in older people.

Authors:  Ali Tomlin; Alan Sinclair
Journal:  Psychol Res Behav Manag       Date:  2016-01-21

Review 10.  The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review.

Authors:  J A Cramer; A Benedict; N Muszbek; A Keskinaslan; Z M Khan
Journal:  Int J Clin Pract       Date:  2007-11-05       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.